Morgan Stanley Uplifts athenahealth (ATHN) Target Price to $135.00

Morgan Stanley Uplifts athenahealth (ATHN) Target Price to $135.00

athenahealth (NASDAQ:ATHN) had its price target hoisted by Morgan Stanley from $128.00 to $135.00 in a research note issued to investors on Monday. The brokerage currently has an equal weight rating on the health services provider’s stock.

A number of other brokerages have also recently commented on ATHN. Leerink Swann set a $138.00 price target on athenahealth and gave the stock a hold rating in a research report on Thursday, November 1st. KeyCorp reduced their price target on athenahealth from $170.00 to $142.00 and set an overweight rating for the company in a research report on Monday, November 12th. BidaskClub upgraded athenahealth from a strong sell rating to a sell rating in a research report on Saturday, October 13th. SunTrust Banks cut athenahealth from a buy rating to a hold rating and reduced their price target for the stock from $150.00 to $135.00 in a research report on Tuesday, November 13th. Finally, Citigroup reduced their price target on athenahealth from $140.00 to $135.00 and set a neutral rating for the company in a research report on Tuesday, November 13th. One investment analyst has rated the stock with a sell rating, twenty have assigned a hold rating and three have issued a buy rating to the stock. athenahealth currently has an average rating of Hold and an average price target of $147.71.

ATHN stock opened at $133.05 on Monday. athenahealth has a fifty-two week low of $116.77 and a fifty-two week high of $163.94. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.74 and a current ratio of 2.74. The stock has a market capitalization of $5.38 billion, a price-to-earnings ratio of 84.75, a PEG ratio of 2.38 and a beta of 0.82.

athenahealth (NASDAQ:ATHN) last posted its earnings results on Friday, November 9th. The health services provider reported $0.81 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.10. athenahealth had a return on equity of 15.35% and a net margin of 9.57%. The company had revenue of $331.40 million for the quarter, compared to the consensus estimate of $336.98 million. During the same quarter in the prior year, the company earned $0.56 earnings per share. athenahealth’s revenue was up 8.8% on a year-over-year basis. On average, equities analysts predict that athenahealth will post 3.15 earnings per share for the current year.

In related news, insider Daniel P. Haley sold 2,204 shares of the stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $127.23, for a total transaction of $280,414.92. Following the completion of the sale, the insider now owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold 2,504 shares of company stock valued at $317,891 in the last quarter. 2.90% of the stock is currently owned by company insiders.

Several large investors have recently added to or reduced their stakes in ATHN. Point72 Hong Kong Ltd grew its holdings in athenahealth by 1,195.2% during the 3rd quarter. Point72 Hong Kong Ltd now owns 816 shares of the health services provider’s stock valued at $109,000 after buying an additional 753 shares in the last quarter. Integrated Investment Consultants LLC bought a new stake in shares of athenahealth in the 2nd quarter valued at approximately $150,000. Ropes Wealth Advisors LLC bought a new stake in shares of athenahealth in the 2nd quarter valued at approximately $194,000. Strs Ohio bought a new stake in shares of athenahealth in the 2nd quarter valued at approximately $208,000. Finally, D.A. Davidson & CO. bought a new stake in shares of athenahealth in the 2nd quarter valued at approximately $223,000. Hedge funds and other institutional investors own 96.15% of the company’s stock.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Further Reading: Balance Sheet

Related posts

Leave a Comment